Ascendis reports fixed-dose TransCon PTH data from phase II PaTH Forward trial in hypoparathyroidism April 20, 2020
Novartis plans phase III study of hydroxychloroquine in hospitalized patients with COVID-19 disease April 20, 2020
Initiation of phase III RUXCOVID trial of ruxolitinib for COVID-19-associated cytokine storm April 20, 2020
FDA approves Tukysa for advanced, unresectable or metastatic HER2-positive breast cancer April 20, 2020
RSS